Aligning Policy to Promote Cascade Genetic Screening for Prevention and Early Diagnosis of Heritable Diseases
- 11 January 2015
- journal article
- Published by Wiley in Journal of Genetic Counseling
- Vol. 24 (3), 388-399
- https://doi.org/10.1007/s10897-014-9805-5
Abstract
Cascade genetic screening is a methodology for identifying and testing close blood relatives of individuals at increased risk for heritable conditions and follows a sequential process, minimizing testing costs and the number of family members who need to be tested. It offers considerable potential for cost savings and increased awareness of heritable conditions within families. CDC-classified Tier 1 genomic applications for hereditary breast and ovarian cancer syndrome (HBOC), Lynch Syndrome (LS), and familial hypercholesterolemia (FH) are recommended for clinical use and support the use of cascade genetic screening. Most individuals are unaware of their increased risk for heritable conditions such as HBOC, LS, and FH. Consistent implementation of cascade genetic screening could significantly increase awareness and prevention of heritable conditions. Limitations to effective implementation of cascade genetic screening include: insufficient genetic risk assessment and knowledge by a majority of healthcare providers without genetics credentials; a shortage of genetic specialists, especially in rural areas; a low rate of reimbursement for comprehensive genetic counseling services; and an individual focus on prevention by clinical guidelines and insurance coverage. The family-centric approach of cascade genetic screening improves prevention and early diagnosis of heritable diseases on a population health level. Cascade genetic screening could be better supported and augmented through changes in health policy.This publication has 37 references indexed in Scilit:
- Patterns of Cancer Genetic Testing: A Randomized Survey of Oregon CliniciansJournal of Cancer Epidemiology, 2012
- Public Health Action in Genomics Is Now Needed beyond Newborn ScreeningPublic Health Genomics, 2012
- A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer SyndromeHereditary Cancer in Clinical Practice, 2012
- Reported referral for genetic counseling or BRCA 1/2 testing among United States physiciansCancer, 2011
- Awareness and Utilization of BRCA1/2 Testing Among U.S. Primary Care PhysiciansAmerican Journal of Preventive Medicine, 2011
- The Search for Unaffected Individuals with Lynch Syndrome: Do the Ends Justify the Means?Cancer Prevention Research, 2011
- A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relativesFamilial Cancer, 2010
- Genetic health professionals and the communication of genetic information in families: Practice during and after a genetic consultationAmerican Journal of Medical Genetics Part A, 2010
- Duty to Warn At-Risk Family Members of Genetic DiseaseThe AMA Journal of Ethic, 2009
- Interviews with primary care physicians regarding taking and interpreting the cancer family historyFamily Practice, 2008